cross-posted from: https://lemmy.ca/post/50438954

“This year, all our pre-filled syringe COVID-19 vaccine doses for Canada are on track to be produced entirely within the country, starting at our new mRNA manufacturing facility in Laval, Quebec, and completed at our fill-finish partner in Cambridge, Ontario,” Raos says.